Analysis and Commentary STEVEN GROSSMAN 6/26/20 Analysis and Commentary STEVEN GROSSMAN 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Advocacy at a Glance STEVEN GROSSMAN 8/11/19 Advocacy at a Glance STEVEN GROSSMAN 8/11/19 BBA Becomes Law; Difficult Path to Appropriation Bills by October 1 Read More Analysis and Commentary STEVEN GROSSMAN 11/4/17 Analysis and Commentary STEVEN GROSSMAN 11/4/17 FDA Is Its People ... and They Need Our Support Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More
Analysis and Commentary STEVEN GROSSMAN 6/26/20 Analysis and Commentary STEVEN GROSSMAN 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Advocacy at a Glance STEVEN GROSSMAN 8/11/19 Advocacy at a Glance STEVEN GROSSMAN 8/11/19 BBA Becomes Law; Difficult Path to Appropriation Bills by October 1 Read More
Analysis and Commentary STEVEN GROSSMAN 11/4/17 Analysis and Commentary STEVEN GROSSMAN 11/4/17 FDA Is Its People ... and They Need Our Support Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More
